• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同步每日顺铂与放疗治疗局部晚期头颈部及支气管鳞状癌。

Concurrent daily cisplatin and radiotherapy in locally advanced squamous carcinoma of the head-and-neck and bronchus.

作者信息

Tobias J S, Smith B J, Blackman G, Finn G

机构信息

Department of Radiotherapy and Oncology, University College Hospital, London, U.K.

出版信息

Radiother Oncol. 1987 Aug;9(4):263-8. doi: 10.1016/s0167-8140(87)80146-9.

DOI:10.1016/s0167-8140(87)80146-9
PMID:3685448
Abstract

In order to exploit the cytotoxic and radiosensitising actions of cis-platinum, we have treated 35 patients with locally advanced squamous cell carcinoma of the bronchus or head-and-neck. Each patient underwent radical irradiation (60 Gy/30 fractions over 6 weeks) with daily low-dose intravenous cisplatin (10 mg absolute dose per day) administered within 30 min of each daily radiation fraction. Total dose of cisplatin was 300 mg over 6 weeks. Although treatment was complicated by nausea in almost all patients and transient renal dysfunction in the majority, 27 patients completed treatment and renal function returned to normal or near normal in almost all cases. There was no obvious enhancement of pulmonary or skin toxicity, beyond what would have been expected from treatment with radical radiotherapy alone. There were two treatment-related deaths from renal failure. The response rate was high: all patients achieved at least a partial response, and in head-and-neck sites, there were nine complete responders and seven partial responders. Of the initial 35 patients, of whom all but two had advanced inoperable disease, 11 have died and 21 remain in continuous remission, 8-120 weeks from the start of treatment (median 55 weeks).

摘要

为了利用顺铂的细胞毒性和放射增敏作用,我们对35例局部晚期支气管或头颈部鳞状细胞癌患者进行了治疗。每位患者接受根治性放疗(6周内60 Gy/30次分割),同时在每次放疗分割的30分钟内每日静脉注射低剂量顺铂(绝对剂量每日10 mg)。顺铂的总剂量在6周内为300 mg。尽管几乎所有患者都出现了恶心,大多数患者出现了短暂的肾功能不全,使治疗变得复杂,但27例患者完成了治疗,几乎所有病例的肾功能都恢复到了正常或接近正常水平。除了单纯根治性放疗预期的毒性外,肺部或皮肤毒性没有明显增强。有2例因肾衰竭导致的与治疗相关的死亡。缓解率很高:所有患者至少达到部分缓解,在头颈部部位,有9例完全缓解者和7例部分缓解者。最初的35例患者中,除2例患者外均为无法手术的晚期疾病,11例患者死亡,21例患者仍处于持续缓解状态,从治疗开始起8 - 120周(中位时间55周)。

相似文献

1
Concurrent daily cisplatin and radiotherapy in locally advanced squamous carcinoma of the head-and-neck and bronchus.同步每日顺铂与放疗治疗局部晚期头颈部及支气管鳞状癌。
Radiother Oncol. 1987 Aug;9(4):263-8. doi: 10.1016/s0167-8140(87)80146-9.
2
[Combined radiotherapy with cis- or carboplatin in advanced head and neck tumors].[晚期头颈部肿瘤中顺铂或卡铂与放疗联合应用]
Strahlenther Onkol. 1989 Sep;165(9):647-51.
3
Concurrent cis-platinum and radiation with or without surgery for advanced head and neck cancer.晚期头颈癌同步顺铂和放疗联合或不联合手术治疗
Int J Radiat Oncol Biol Phys. 1994 Dec 1;30(5):1043-50. doi: 10.1016/0360-3016(94)90308-5.
4
Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study.局部晚期头颈癌治疗中快速交替化疗与超分割放疗:一项I/II期研究的四年结果
J Clin Oncol. 1994 Sep;12(9):1876-85. doi: 10.1200/JCO.1994.12.9.1876.
5
[SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].同步放化疗联合顺铂治疗局部晚期头颈部鳞状细胞癌(SCHNC)。早期结果及毒性评估
Otolaryngol Pol. 2011 Sep;65(5 Suppl):117-25. doi: 10.1016/S0030-6657(11)70719-3.
6
Concomitant cisplatin and hyperfractionated radiotherapy in locally advanced head and neck cancer: 10-year follow-up of a randomized phase III trial (SAKK 10/94).同期顺铂和超分割放疗局部晚期头颈部癌:随机 III 期试验(SAKK 10/94)的 10 年随访结果。
Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):524-31. doi: 10.1016/j.ijrobp.2010.11.067. Epub 2011 Feb 16.
7
Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck. An RTOG Study.
Cancer. 1987 Jan 15;59(2):259-65. doi: 10.1002/1097-0142(19870115)59:2<259::aid-cncr2820590214>3.0.co;2-1.
8
Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol.超分割放疗联合5-氟尿嘧啶、顺铂和紫杉醇(泰素)治疗Ⅲ期和Ⅳ期不可手术和/或无法切除的头颈部鳞状细胞癌的耐受性和疗效的Ⅱ期研究:A-2方案
Int J Radiat Oncol Biol Phys. 2002 Jul 15;53(4):942-7. doi: 10.1016/s0360-3016(02)02816-x.
9
[Simultaneous cisplatin and radiotherapy of locally advanced squamous cell carcinomas of the head and neck region. A clinical pilot study].[头颈部局部晚期鳞状细胞癌的顺铂与放疗同步治疗。一项临床试点研究]
Dtsch Med Wochenschr. 1983 Nov 18;108(46):1743-5. doi: 10.1055/s-2008-1069818.
10
Induction chemotherapy with S-1 plus cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck.S-1联合顺铂用于局部晚期头颈部鳞状细胞癌患者的诱导化疗。
J Laryngol Otol. 2008 Aug;122(8):848-53. doi: 10.1017/S0022215107001181. Epub 2007 Nov 30.

引用本文的文献

1
Long term results of comparison of concurrent low-dose daily cisplatin versus the standard weekly cisplatin with six fractions per week radiotherapy in locally advanced head neck cancer.局部晚期头颈癌患者中,每日低剂量顺铂同步放疗与标准每周一次顺铂(每周六次分割放疗)对比的长期结果。
South Asian J Cancer. 2016 Apr-Jun;5(2):80-4. doi: 10.4103/2278-330X.181647.
2
Current role of chemotherapy in head and neck cancer.化疗在头颈癌中的当前作用。
Drugs. 1992 Mar;43(3):333-45. doi: 10.2165/00003495-199243030-00004.